Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$1.5B
Avg Funding
$58.0M
Cities
21

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Uppsala, Sweden
$16.4M
raised

OssDsign is a medical-technology company developing implants for bone replacement.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$5.6M
raised

Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$125.0M
raised

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

May 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Göteborg, Sweden
$463K
raised

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

May 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Louisville, United States
$96.9M
raised

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$8.0M
raised

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$3.0M
raised

Cyclezyme has created an enzymatic platform aimed at manufacturing enzymes for green biochemical processes.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boulder, United States
$200.0M
raised

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$175.0M
raised

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Irvine, United States
$125.0M
raised

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Newport Beach, United States
$5.0M
raised

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$9.6M
raised

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Tarpon Springs, United States
$3.3M
raised

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$105.0M
raised

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$8.0M
raised

Mustang Bio is a clinical-stage biopharmaceutical company .

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Watertown, United States
$185.0M
raised

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Feb 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$287.5M
raised

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$3.9M
raised

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Simrishamn, Sweden
$454K
raised

Prebona is a nanotechnology firm that develops products and solutions for the healthcare, transportation, agriculture and textile industry.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seinäjoki, Finland
$1.1M
raised

Eevia Health is a Finnish-Norwegian life science company.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Carlton South, Australia
$5.0M
raised

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$30.0M
raised

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$50.0M
raised

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$224K
raised

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$1.6M
raised

PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 301 to 325 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

483 Biotechnology Post-IPO Equity Startups (November 2026) — Page 13 | VCBacked